New Thematic Issue
This month we are highlighting the latest updates in transgender health with a special collection of journal articles, published in 2017–2019. This free online collection features notable basic and clinical findings from our family of journals.
CEU Miami 2019
Receive the latest updates in clinical endocrinology care from renowned experts at Clinical Endocrinology Update (CEU) in Miami, Florida, Sept. 5–7. Network with hundreds of peers and earn up to 21.50 AMA PRA Category 1 Credits™. Register today!
EBR/CEU Seattle 2019
Join us in Seattle, Washington, for Endocrine Board Review (EBR), Sept. 17–18, and Clinical Endocrinology Update (CEU), Sept. 19–21. Assess you clinical knowledge at EBR and learn the latest updates at CEU. Reigster before Aug. 1 to save!
We partnered with Keystone Symposia to record ten sessions, featuring 27 presentations, from the Scientific Pathways at ENDO 2019. These presentations are now available and free to access.
- Advocacy in Action: NIH Funding, Transgender Protections, Drug Pricing and more...
- One Step Closer: Is Male Hormonal Contraception Finally Within Reach?
- V. Craig Jordan Honored by Queen Elizabeth II
- Lab Notes: Greener Labs—Considering your lab probably consumes more energy than your entire home, it might be time to look at a number of options to make your laboratory more energy friendly.
Enhance your patient care at Clinical Endocrinology Update (CEU), offered in Miami, Florida September 5-7, and Seattle, Washington, September 19-21. Receive the latest updates in clinical endocrinology care from renowned experts and network with hundreds of colleagues from around the world. This year's can't-miss sessions include:
- Helping Patients Find Motivation for Lifestyle Change—Scott Kahan, MD, MPH
- Testosterone Replacement Modalities: Pros, Cons, and Their Correct Use—Shehzad S. Basaria, MD
- Controversies in the Treatment of Women With Menopausal Hormones—Margaret E. Wierman, MD; Cynthia Stuenkel, MD
- Challenges with Technology: Difficult Pump and CGM Cases—Anders L. Carlson, MD
- Diagnosis and Management of Adrenal Insufficiency—Lynnette K. Nieman, MD
Endocrine Board Review (EBR) is a case-based course and mock exam that will allow you to test your knowledge in everyday practice. This course is ideal for those seeking an intensive knowledge assessment, as well as for endocrine fellows and physicians preparing to take the endocrine board exam. The distinguished faculty includes Serge A. Jabbour, MD; Richard Auchus, MD, PhD; Carolyn Becker, MD; and many more. View the full EBR Program.
- June 22 - 25, 2019 | 9th International Conference on Childrens Bone Health | Salzburg, Austria
- July 4 - 5, 2019 | ThyroAlex 9 | Alexandria, Alexandria, Egypt
- July 7 - 12, 2019 | Growth Hormone and Prolactin Family in Biology and Disease | West Palm Beach, Florida, United States
Experience the best of ENDO 2019 and earn 150 AMA PRA Category 1 Credits™. ENDO 2019 Session Recordings contain almost 200 hours of on-demand clinical content from some of the most distinguished experts in the field. Learn on-the-go with downloadable MP3 files of presentation audio, available on iPhone, iPad, and Android devices. Purchase today.
Although diagnosis and management of functional and neoplastic long-term consequences of cancer therapy are comparable to other causes of endocrine disorders, cancer survivors need individually structured follow-up care in specialized surveillance centers to improve care for this rapidly growing group of patients.
In the last few years, a series of articles has unveiled a previous unknown relation of these kinases with metabolic regulation and the homeostasis of metabolic tissues. The aim of this review is to bring together this body of data to provide a detailed picture of the current knowledge about these proteins, metabolism, and some of the associated diseases.
In this review, important issues pertaining to the treatment of children with CPP are discussed.
Although survivors had lower levels of AMH and AFC at the time of enrollment, the rate of change of AMH and AFC is not significantly different than similar-aged controls.